NCT00513071View on ClinicalTrials.gov

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Hormone-resistant Prostate CancerRecurrent Prostate Cancer
Interventions
DRUG

saracatinib

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00513071 - AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | Biotech Hunter | Biotech Hunter